Welcome to the Q4 2022 edition of our competition law newsletter. This is our quarterly update covering key developments in UK and EU competition law.
Highlights of this edition include:
- CMA continues its robust approach to Phase 2 reviews
- Pfizer and Flynn launch fresh appeals in the face of revised CMA fines for excessive pricing
- New CPO valued at £900 million to be launched against Amazon in relation its 'buy box' function
- Abuse of dominance and tech - The saga continues with the CMA's probe of Apple/Google duopoly
- Waiting in the shadows - Introduction of the CMA's digital markets regulator expected in October 2023
- Broadcom faces scrutiny for VMware acquisition despite apparent lack of overlaps
- Nexperia / Newport deal prohibition – Legitimate national security concerns or wafer thin justifications?
- CMA calls time on Emma Group's use of countdown clocks by opening consumer protection investigation
- BMW fined by CMA for failure to comply with document production notice
- Commission consults on a revised Market Definition Notice
- Commission adopts Notice on Informal Guidance
- Commission publishes guidelines discharging gig economy workers from the competition rules
- ECJ clarifies that disclosure of relevant evidence in antitrust damages claims applies to both existing and ex novo evidence
- Commission publishes new guidance on its leniency programme
Wishing you all a joyful and festive season and prosperous New Year!
Download PDF